Article
Chromatin organization in myelodysplastic syndrome.
Experimental hematology - 1 Jun 2024
Xu Jane Jialu, Viny Aaron D
Abstract excerpt
Disordered chromatin organization has emerged as a new aspect of the pathogenesis of myelodysplastic syndrome (MDS). Characterized by lineage dysplasia and a high transformation rate to acute myeloid leukemia (AML), the genetic determinant of MDS is thought to be the main driver of the disease's progression. Among the recurrently mutated pathways, alterations in chromatin organization, such as the cohesin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
